Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPAP plus carbocysteine versus CPAP alone for blood pressure in OSAHS
ChiCTR-IPR-15006614Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of carbocisteine in obstructive sleep apnea hypopnea syndrome (OSAHS) and hypertension (HTN) (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: blood pressure. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
carbocisteine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-IPR-15006614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006614.